Patel V - Search Results

1

Intertypic genomic rearrangements of poliovirus strains in vaccinees.

Cammack N, Phillips A, Dunn G, Patel V, Minor PD. Cammack N, et al. Among authors: patel v. Virology. 1988 Dec;167(2):507-14. Virology. 1988. PMID: 2849237

2

Antigenic sites on type 2 poliovirus.

Patel V, Ferguson M, Minor PD. Patel V, et al. Virology. 1993 Jan;192(1):361-4. doi: 10.1006/viro.1993.1044. Virology. 1993. PMID: 7685967

3

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Martín J, Dunn G, Hull R, Patel V, Minor PD. Martín J, et al. Among authors: patel v. J Virol. 2000 Apr;74(7):3001-10. doi: 10.1128/jvi.74.7.3001-3010.2000. J Virol. 2000. PMID: 10708414 Free PMC article.

4

The production and characterisation of monoclonal antibodies against human prolactin and the development of a two-site immunoradiometric assay.

Baines MG, Rafferty B, Patel V, Ferguson K, Jeffcoate SL, Thorpe R. Baines MG, et al. Among authors: patel v. J Immunoassay. 1989;10(1):75-91. doi: 10.1080/01971528908053228. J Immunoassay. 1989. PMID: 2715347

5

Antisera raised against recombinant soluble CD4s can have reactivity to recombinant HIV-1 envelope glycoproteins.

Page M, Patel VR, Dilger P, Ling CR, Thorpe R. Page M, et al. Among authors: patel vr. AIDS. 1991 Mar;5(3):321-4. doi: 10.1097/00002030-199103000-00013. AIDS. 1991. PMID: 1711862

6

Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB).

Page M, Mills KH, Schild GC, Ling C, Patel V, McKnight A, Barnard AL, Dilger P, Thorpe R. Page M, et al. Among authors: patel v. Vaccine. 1991 Jan;9(1):47-52. doi: 10.1016/0264-410x(91)90316-x. Vaccine. 1991. PMID: 2008801

7

A Proof-of-Concept for Safety Evaluation of Inhalation Exposure to Known Respiratory Irritants Using In Vitro and In Silico Methods.

Sadekar N, Behrsing HP, Hansen T, Patel V, Paulo H, Rae A, Ritter D, Schwarz K, Api AM. Sadekar N, et al. Among authors: patel v. Toxics. 2025 Jan 4;13(1):35. doi: 10.3390/toxics13010035. Toxics. 2025. PMID: 39853033

8

Decoding the Therapeutic Target SVEP1: Harnessing Molecular Trait GWASs to Unravel Mechanisms of Human Disease.

Elenbaas JS, Lee PC, Patel V, Stitziel NO. Elenbaas JS, et al. Among authors: patel v. Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):131-148. doi: 10.1146/annurev-pharmtox-061724-080905. Annu Rev Pharmacol Toxicol. 2025. PMID: 39847464 Review.

9

Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects.

Hassall J, Coxon C, Patel VC, Goldenberg SD, Sergaki C. Hassall J, et al. Among authors: patel vc. NPJ Antimicrob Resist. 2024 Jun 17;2(1):16. doi: 10.1038/s44259-024-00033-8. NPJ Antimicrob Resist. 2024. PMID: 39843577 Free PMC article. Review.

10

Use and Spending on Medical Equipment Among US Cancer Survivors.

Jafri FI, Patel VR, Qasim Hussaini SM, Premnath N, Parsons HM, Blaes AH, Gupta A. Jafri FI, et al. Among authors: patel vr. JAMA Netw Open. 2025 Jan 2;8(1):e2455941. doi: 10.1001/jamanetworkopen.2024.55941. JAMA Netw Open. 2025. PMID: 39841478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,186 results

Search Page

Filters